Follow
Jitao David Zhang
Jitao David Zhang
A computational biologist in drug discovery
Verified email at roche.com - Homepage
Title
Cited by
Cited by
Year
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
G Sturm, F Finotello, F Petitprez, JD Zhang, J Baumbach, WH Fridman, ...
Bioinformatics 35 (14), i436-i445, 2019
6222019
KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor
JD Zhang, S Wiemann
Bioinformatics 25 (11), 1470-1471, 2009
3372009
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
A Ward, A Balwierz, JD Zhang, M Küblbeck, Y Pawitan, T Hielscher, ...
Oncogene 32 (9), 1173-1182, 2013
3322013
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways
I Keklikoglou, C Koerner, C Schmidt, JD Zhang, D Heckmann, ...
Oncogene 31 (37), 4150, 2012
3242012
An introduction to machine learning
S Badillo, B Banfai, F Birzele, II Davydov, L Hutchinson, T Kam‐Thong, ...
Clinical Pharmacology & Therapeutics 107 (4), 871-885, 2020
3212020
MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F
S Jurmeister, M Baumann, A Balwierz, I Keklikoglou, A Ward, S Uhlmann, ...
Molecular and cellular biology 32 (3), 633-651, 2012
2872012
miR-200bc/429 cluster targets PLCγ1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer
S Uhlmann, JD Zhang, A Schwäger, H Mannsperger, Y Riazalhosseini, ...
Oncogene 29 (30), 4297-4306, 2010
2582010
Assessment of network module identification across complex diseases
S Choobdar, ME Ahsen, J Crawford, M Tomasoni, T Fang, D Lamparter, ...
Nature Methods 16 (9), 843-852, 2019
2402019
Global microRNA level regulation of EGFR‐driven cell‐cycle protein network in breast cancer
S Uhlmann, H Mannsperger, JD Zhang, EÁ Horvat, C Schmidt, ...
Molecular systems biology 8 (1), 570, 2012
2292012
White-to-brown metabolic conversion of human adipocytes by JAK inhibition
A Moisan, YK Lee, JD Zhang, CS Hudak, CA Meyer, M Prummer, ...
Nature cell biology 17 (1), 57-67, 2015
1862015
14-3-3ζ turns TGF-β’s function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2
J Xu, S Acharya, O Sahin, Q Zhang, Y Saito, J Yao, H Wang, P Li, L Zhang, ...
Cancer Cell 27 (2), 177-192, 2015
1822015
Localization‐and mutation‐dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co‐expressed miRNAs located at 14q32. 31
F Haller, A von Heydebreck, JD Zhang, B Gunawan, C Langer, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010
1532010
A novel orally available small molecule that inhibits hepatitis B virus expression
H Mueller, S Wildum, S Luangsay, J Walther, A Lopez, P Tropberger, ...
Journal of hepatology 68 (3), 412-420, 2018
1282018
Plasma microRNA profiles for bladder cancer detection
L Adam, MF Wszolek, CG Liu, W Jing, L Diao, A Zien, JD Zhang, ...
Urologic Oncology: Seminars and Original Investigations 31 (8), 1701-1708, 2013
992013
MicroRNAs: master regulators of drug resistance, stemness, and metastasis
U Raza, JD Zhang, Ö Şahin
Journal of molecular medicine 92, 321-336, 2014
882014
Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity
JD Zhang, N Berntenis, A Roth, M Ebeling
The pharmacogenomics journal 14 (3), 208-216, 2014
792014
Large-Scale Production of Human iPSC-Derived Macrophages for Drug Screening
S Gutbier, F Wanke, N Dahm, A Rümmelin, S Zimmermann, ...
International Journal of Molecular Sciences 21 (13), 4808, 2020
722020
ddCt method for qRT–PCR data analysis
JD Zhang, M Ruschhaupt, R Biczok
Citeseer 48 (4), 346-356, 2013
632013
Effects of copper on CHO cells: insights from gene expression analyses
IH Yuk, JD Zhang, M Ebeling, M Berrera, N Gomez, S Werz, C Meiringer, ...
Biotechnology progress 30 (2), 429-442, 2014
612014
The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
JD Raza, U and Saatci, {\"O} and Uhlmann, S and Ansari, SA and Ey{\"u}po{\"A ...
Oncotarget, 2016
582016
The system can't perform the operation now. Try again later.
Articles 1–20